A young kiwi patient will be one of the first to be treated with a radical new treatment for a rare disease.
The drug will be used to target muscle cells and silence a gene which causes Facioscapulohumeral Muscular Dystrophy.
Neurologist and trial lead Richard Roxburgh says the method is promising.
LISTEN ABOVE

Mike's Minute: Moana Pasifika showed the market was right
02:04

Steven Joyce: Former Finance Minister previews Budget 2026, backs public sector cuts
07:19

Marcos Pelenur: Energy Efficiency and Conservation Authority CEO on the public ad campaign on how to save fuel
03:22